These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 23358860)

  • 1. Further analysis of the Crouzon mouse: effects of the FGFR2(C342Y) mutation are cranial bone-dependent.
    Liu J; Nam HK; Wang E; Hatch NE
    Calcif Tissue Int; 2013 May; 92(5):451-66. PubMed ID: 23358860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The craniofacial phenotype of the Crouzon mouse: analysis of a model for syndromic craniosynostosis using three-dimensional MicroCT.
    Perlyn CA; DeLeon VB; Babbs C; Govier D; Burell L; Darvann T; Kreiborg S; Morriss-Kay G
    Cleft Palate Craniofac J; 2006 Nov; 43(6):740-8. PubMed ID: 17105336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of
    Lee KKL; Peskett E; Quinn CM; Aiello R; Adeeva L; Moulding DA; Stanier P; Pauws E
    Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic background dependent modifiers of craniosynostosis severity.
    Dudakovic A; Nam HK; Wijnen AJV; Hatch NE
    J Struct Biol; 2020 Dec; 212(3):107629. PubMed ID: 32976998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craniosynostosis-associated Fgfr2(C342Y) mutant bone marrow stromal cells exhibit cell autonomous abnormalities in osteoblast differentiation and bone formation.
    Liu J; Kwon TG; Nam HK; Hatch NE
    Biomed Res Int; 2013; 2013():292506. PubMed ID: 23762837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchondrosis fusion contributes to the progression of postnatal craniofacial dysmorphology in syndromic craniosynostosis.
    Hoshino Y; Takechi M; Moazen M; Steacy M; Koyabu D; Furutera T; Ninomiya Y; Nuri T; Pauws E; Iseki S
    J Anat; 2023 Mar; 242(3):387-401. PubMed ID: 36394990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-Phenotype Correlation of Tracheal Cartilaginous Sleeves and Fgfr2 Mutations in Mice.
    Lam AS; Liu CC; Deutsch GH; Rivera J; Perkins JA; Holmes G; Jabs EW; Cunningham ML; Dahl JP
    Laryngoscope; 2021 Apr; 131(4):E1349-E1356. PubMed ID: 32886384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New CRISPR/Cas9-based Fgfr2
    Yue YY; Lai CZ; Guo XS; Yang CS; Wang Y; Song GD; Jin XL
    J Mol Med (Berl); 2024 Oct; 102(10):1255-1266. PubMed ID: 39158595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of tissue-non-specific alkaline phosphatase gene therapy on craniosynostosis and craniofacial morphology in the FGFR2C342Y/+ mouse model of Crouzon craniosynostosis.
    Wang E; Nam HK; Liu J; Hatch NE
    Orthod Craniofac Res; 2015 Apr; 18 Suppl 1(0 1):196-206. PubMed ID: 25865549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIN1 Attenuation Improves Midface Hypoplasia in a Mouse Model of Apert Syndrome.
    Kim B; Shin H; Kim W; Kim H; Cho Y; Yoon H; Baek J; Woo K; Lee Y; Ryoo H
    J Dent Res; 2020 Feb; 99(2):223-232. PubMed ID: 31869252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific responses to aberrant FGF signaling in complex head phenotypes.
    Martínez-Abadías N; Motch SM; Pankratz TL; Wang Y; Aldridge K; Jabs EW; Richtsmeier JT
    Dev Dyn; 2013 Jan; 242(1):80-94. PubMed ID: 23172727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cranial bone microarchitecture in a mouse model for syndromic craniosynostosis.
    Ajami S; Van den Dam Z; Hut J; Savery D; Chin M; Koudstaal M; Steacy M; Carriero A; Pitsillides A; Chang YM; Rau C; Marathe S; Dunaway D; Jeelani NUO; Schievano S; Pauws E; Borghi A
    J Anat; 2024 Dec; 245(6):864-873. PubMed ID: 39096036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crouzon syndrome mouse model exhibits cartilage hyperproliferation and defective segmentation in the developing trachea.
    Hines EA; Jones MN; Harvey JF; Perlyn C; Ornitz DM; Sun X; Verheyden JM
    Sci China Life Sci; 2019 Oct; 62(10):1375-1380. PubMed ID: 31463736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fgfr2 W290R mouse model of Crouzon syndrome.
    Gong SG
    Childs Nerv Syst; 2012 Sep; 28(9):1495-503. PubMed ID: 22872266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational mouse atlases and their application to automatic assessment of craniofacial dysmorphology caused by the Crouzon mutation Fgfr2(C342Y).
    Olafsdóttir H; Darvann TA; Hermann NV; Oubel E; Ersbøll BK; Frangi AF; Larsen P; Perlyn CA; Morriss-Kay GM; Kreiborg S
    J Anat; 2007 Jul; 211(1):37-52. PubMed ID: 17553099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
    Ang BU; Spivak RM; Nah HD; Kirschner RE
    J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extremely severe scoliosis, heterotopic ossification, and osteoarthritis in a three-generation family with Crouzon syndrome carrying a mutant c.799T>C FGFR2.
    Lin M; Lu Y; Sui Y; Zhao N; Jin Y; Yi D; Jiang M
    Mol Genet Genomic Med; 2019 Sep; 7(9):e843. PubMed ID: 31318164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midface and upper airway dysgenesis in FGFR2-related craniosynostosis involves multiple tissue-specific and cell cycle effects.
    Holmes G; O'Rourke C; Motch Perrine SM; Lu N; van Bakel H; Richtsmeier JT; Jabs EW
    Development; 2018 Oct; 145(19):. PubMed ID: 30228104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe craniolacunae and upper and lower extremity anomalies resulting from Crouzon syndrome, FGFR2 mutation, and Ser347Cys variant.
    Raposo-Amaral CE; Oliveira YM; Denadai R; Raposo-Amaral CA; Ghizoni E
    Childs Nerv Syst; 2021 Jul; 37(7):2391-2397. PubMed ID: 33404724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
    Mansukhani A; Bellosta P; Sahni M; Basilico C
    J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.